NT-proBNP-Possible Prognostic Marker in Pregnant Patients with Associated Cardiovascular Risk Factors and SARS-CoV-2 Infection.

Carmen-Ioana MartaAnca Laura MaghiariElena Silvia BernadLavinia SteleaBrenda BernadLioara BoscuRadu NeamtuAdrian GluhovschiMircea DiaconuCatalin DumitruBogdan SoropKatalin Babes

Published in: Diagnostics (Basel, Switzerland) (2023)

NT-proBNP testing in pregnant patients with SARS-CoV-2 infection can be a relatively important marker to be taken into consideration when it comes to the management, treatment and outcome of the cases, especially when it comes to women with associated cardiovascular risk factors.

Keyphrases

cardiovascular risk factors
cardiovascular disease
metabolic syndrome
pregnant women
respiratory syndrome coronavirus
type diabetes
sars cov
combination therapy
coronavirus disease
smoking cessation